BIOMAT Database Logo BIOMAT Database Logo

Pembrolizumab treatment for progressive multifocal leukoencephalopathy in a patient with Human Immunodeficiency Virus infection. 2020

Marta Mozo Ruiz, and Noemí Rosado Barrasa, and Daniel Tena Gómez, and Miguel Torralba González de Suso
Servicio de Medicina Interna, Hospital Universitario de Guadalajara, Guadalajara, España. Electronic address: martamozo.rz@gmail.com.

UI MeSH Term Description Entries
D007968 Leukoencephalopathy, Progressive Multifocal An opportunistic viral infection of the central nervous system associated with conditions that impair cell-mediated immunity (e.g., ACQUIRED IMMUNODEFICIENCY SYNDROME and other IMMUNOLOGIC DEFICIENCY SYNDROMES; HEMATOLOGIC NEOPLASMS; IMMUNOSUPPRESSION; and COLLAGEN DISEASES). The causative organism is JC Polyomavirus (JC VIRUS) which primarily affects oligodendrocytes, resulting in multiple areas of demyelination. Clinical manifestations include DEMENTIA; ATAXIA; visual disturbances; and other focal neurologic deficits, generally progressing to a vegetative state within 6 months. (From Joynt, Clinical Neurology, 1996, Ch26, pp36-7) Encephalitis, JC Polyomavirus,Progressive Multifocal Leukoencephalopathy,JC Polyomavirus Encephalopathy,Encephalopathies, JC Polyomavirus,Encephalopathy, JC Polyomavirus,JC Polyomavirus Encephalitis,Leukoencephalopathies, Progressive Multifocal,Multifocal Leukoencephalopathies, Progressive,Multifocal Leukoencephalopathy, Progressive,Progressive Multifocal Leukoencephalopathies
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D061067 Antibodies, Monoclonal, Humanized Antibodies from non-human species whose protein sequences have been modified to make them nearly identical with human antibodies. If the constant region and part of the variable region are replaced, they are called humanized. If only the constant region is modified they are called chimeric. INN names for humanized antibodies end in -zumab. Antibodies, Humanized,Humanized Antibodies

Related Publications

Marta Mozo Ruiz, and Noemí Rosado Barrasa, and Daniel Tena Gómez, and Miguel Torralba González de Suso
Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy.
April 2019, The New England journal of medicine,
Marta Mozo Ruiz, and Noemí Rosado Barrasa, and Daniel Tena Gómez, and Miguel Torralba González de Suso
Pembrolizumab for progressive multifocal leukoencephalopathy due to primary immunodeficiency.
November 2019, Neurology(R) neuroimmunology & neuroinflammation,
Marta Mozo Ruiz, and Noemí Rosado Barrasa, and Daniel Tena Gómez, and Miguel Torralba González de Suso
[Progressive multifocal leukoencephalopathy and human immunodeficiency virus infection: noninvasive diagnosis].
July 2000, Medicina clinica,
Marta Mozo Ruiz, and Noemí Rosado Barrasa, and Daniel Tena Gómez, and Miguel Torralba González de Suso
Treatment of Progressive Multifocal Leukoencephalopathy with Pembrolizumab.
April 2019, The New England journal of medicine,
Marta Mozo Ruiz, and Noemí Rosado Barrasa, and Daniel Tena Gómez, and Miguel Torralba González de Suso
Progressive multifocal leukoencephalopathy in patients with human immunodeficiency virus.
June 1992, Human pathology,
Marta Mozo Ruiz, and Noemí Rosado Barrasa, and Daniel Tena Gómez, and Miguel Torralba González de Suso
Progressive multifocal leukoencephalopathy as an AIDS-defining condition in a patient with human immunodeficiency virus infection.
May 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
Marta Mozo Ruiz, and Noemí Rosado Barrasa, and Daniel Tena Gómez, and Miguel Torralba González de Suso
Single-Dose Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy.
July 2021, Neurology(R) neuroimmunology & neuroinflammation,
Marta Mozo Ruiz, and Noemí Rosado Barrasa, and Daniel Tena Gómez, and Miguel Torralba González de Suso
Mirtazapine and mefloquine therapy for progressive multifocal leukoencephalopathy in a patient infected with human immunodeficiency virus.
March 2012, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists,
Marta Mozo Ruiz, and Noemí Rosado Barrasa, and Daniel Tena Gómez, and Miguel Torralba González de Suso
A cerebellar tremor in a patient with human immunodeficiency virus-1 associated with progressive multifocal leukoencephalopathy.
October 2009, Journal of movement disorders,
Marta Mozo Ruiz, and Noemí Rosado Barrasa, and Daniel Tena Gómez, and Miguel Torralba González de Suso
Progressive multifocal leukoencephalopathy in a patient without immunodeficiency.
January 2012, Neurology,
Copied contents to your clipboard!